cbdMD, Inc. (YCBDPA) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
8845 RED OAK BOULEVARD CHARLOTTE, NC 28217 |
| State of Incorp. | NC |
| Fiscal Year End | September 30 |
| Industry (SIC) | 2844 - Perfumes, Cosmetics, and Other Toilet Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
| 6/30/2025 Q3 | 3/31/2025 Q2 | 12/31/2024 Q1 | 9/30/2024 Q4 | 6/30/2024 Q3 | 3/31/2024 Q2 | 12/31/2023 Q1 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 1,765 | 1,970 | 2,453 | 2,395 | 2,105 | 1,505 | |||
| Cash and cash equivalent | 1,765 | 1,970 | 2,453 | 2,395 | 2,105 | 1,505 | |||
| Receivables | 695 | 631 | 622 | 916 | 868 | 577 | |||
| Inventory, net of allowances, customer advances and progress billings | 2,884 | 2,473 | 2,524 | 3,226 | 3,452 | 3,743 | |||
| Inventory | 2,884 | 2,473 | 2,524 | 3,226 | 3,452 | 3,743 | |||
| Other undisclosed current assets | 848 | 1,286 | 791 | 752 | 985 | 1,542 | |||
| Total current assets: | 6,192 | 6,361 | 6,389 | 7,289 | 7,410 | 7,366 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 1,043 | 1,209 | 86 | 2,468 | 2,766 | 3,060 | |||
| Property, plant and equipment | 433 | 512 | 454 | 553 | 668 | 790 | |||
| Long-term investments and receivables | 700 | 700 | 700 | 700 | 700 | 700 | |||
| Long-term investments | 700 | 700 | 700 | 700 | 700 | 700 | |||
| Intangible assets, net (including goodwill) | 2,507 | 2,698 | 2,890 | 2,701 | 2,873 | 3,046 | |||
| Intangible assets, net (excluding goodwill) | 2,507 | 2,698 | 2,890 | 2,701 | 2,873 | 3,046 | |||
| Deposits noncurrent assets | 63 | 63 | 63 | 132 | 132 | 132 | |||
| Total noncurrent assets: | 4,745 | 5,182 | 4,192 | 6,554 | 7,140 | 7,729 | |||
| TOTAL ASSETS: | 10,938 | 11,543 | 10,581 | 13,844 | 14,550 | 15,095 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 1,897 | 1,937 | 2,174 | 2,489 | 2,573 | 4,669 | |||
| Accounts payable | 1,288 | 1,161 | 1,541 | 1,273 | 1,291 | 1,567 | |||
| Accrued liabilities | 610 | 776 | 633 | 1,216 | 1,282 | 3,102 | |||
| Deferred revenue | 557 | 527 | 503 | 550 | 468 | ||||
| Debt | 362 | 1,171 | |||||||
| Other undisclosed current liabilities | 7,417 | 6,343 | 4,770 | 4,818 | 3,895 | 1,303 | |||
| Total current liabilities: | 9,872 | 9,170 | 8,618 | 7,857 | 6,937 | 5,972 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 1,378 | 2,702 | |||||||
| Long-term debt, excluding current maturities | 1,378 | 2,702 | |||||||
| Liabilities, other than long-term debt | 400 | 592 | 1,581 | 1,825 | 2,087 | ||||
| Operating lease, liability | 400 | 592 | 1,581 | 1,825 | 2,066 | ||||
| Business combination, contingent consideration, liability | 21 | ||||||||
| Total noncurrent liabilities: | 400 | 592 | 2,959 | 4,527 | 2,087 | ||||
| Total liabilities: | 10,272 | 9,761 | 8,618 | 10,815 | 11,463 | 8,058 | |||
| Equity | |||||||||
| Equity, attributable to parent, including: | 666 | 1,782 | 1,963 | 3,028 | 3,087 | 7,037 | |||
| Preferred stock | 5 | 5 | 5 | 5 | 5 | 5 | |||
| Common stock | 1 | 6 | 4 | 4 | 3 | 3 | |||
| Additional paid in capital | 185,195 | 184,832 | 184,030 | 183,933 | 183,457 | 183,390 | |||
| Accumulated other comprehensive loss | (8) | (7) | (1) | (6) | |||||
| Accumulated deficit | (184,535) | (183,053) | (182,068) | (180,913) | (180,372) | (176,361) | |||
| Other undisclosed equity, attributable to parent | (0) | ||||||||
| Total equity: | 666 | 1,782 | 1,963 | 3,028 | 3,087 | 7,037 | |||
| TOTAL LIABILITIES AND EQUITY: | 10,938 | 11,543 | 10,581 | 13,844 | 14,550 | 15,095 | |||
Income Statement (P&L) ($ in thousands)Annual | Quarterly
| 6/30/2025 Q3 | 3/31/2025 Q2 | 12/31/2024 Q1 | 9/30/2024 Q4 | 6/30/2024 Q3 | 3/31/2024 Q2 | 12/31/2023 Q1 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 4,749 | 5,113 | 4,556 | 5,174 | 4,377 | 5,375 | ||
| Cost of revenue | (1,790) | (1,713) | (2,103) | (1,770) | (1,796) | (1,818) | ||
| Gross profit: | 2,959 | 3,401 | 2,454 | 3,404 | 2,581 | 3,557 | ||
| Other undisclosed operating loss | (3,445) | (3,487) | (2,770) | (3,786) | (4,132) | (4,623) | ||
| Operating loss: | (486) | (86) | (317) | (382) | (1,551) | (1,066) | ||
| Loss from continuing operations before equity method investments, income taxes: | (486) | (86) | (317) | (382) | (1,551) | (1,066) | ||
| Other undisclosed income (loss) from continuing operations before income taxes | 5 | 101 | 164 | 842 | (1,460) | 69 | ||
| Net income (loss) attributable to parent: | (481) | 15 | (153) | 460 | (3,011) | (997) | ||
| Preferred stock dividends and other adjustments | (1,001) | (1,001) | (1,003) | (1,001) | (1,001) | (1,001) | ||
| Net loss available to common stockholders, diluted: | (1,481) | (985) | (1,155) | (541) | (4,011) | (1,997) | ||
Comprehensive Income ($ in thousands)Annual | Quarterly
| 6/30/2025 Q3 | 3/31/2025 Q2 | 12/31/2024 Q1 | 9/30/2024 Q4 | 6/30/2024 Q3 | 3/31/2024 Q2 | 12/31/2023 Q1 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | (481) | 15 | (153) | 460 | (3,011) | (997) | ||
| Comprehensive income (loss): | (481) | 15 | (153) | 460 | (3,011) | (997) | ||
| Other undisclosed comprehensive loss, net of tax, attributable to parent | (1,001) | (1,001) | (1,001) | (996) | (1,007) | (1,001) | ||
| Comprehensive loss, net of tax, attributable to parent: | (1,481) | (985) | (1,154) | (536) | (4,017) | (1,997) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.